Financials · NRXS

Neuraxis Inc. (NRXS) financials

For the twelve months ended Sep 30, 2026, Neuraxis Inc. reported $6.53M of revenue and -$12.10M of net income.

Revenue, TTM
$6.53M
Revenue growth, YoY
+94.3%
Net income, TTM
-$12.10M
Net margin
-185.2%
Cash
$4.48M
P/S
11.78
Market cap
$76.9M
Annual revenue$3.57M
FY2022FY2025
Annual net income-$7.80M
FY2022FY2025
Annual free cash flow-$6.46M
FY2022FY2025

NRXS revenue and earnings growth

NRXS revenueQ3 2026$2.03M

Quarter YoY
+149.9%
QoQ
+5.1%
FY YoY
+32.9%

NRXS revenue was $2.03M in fiscal Q3 2026 (ended Sep 30, 2026), up 149.9% from a year earlier and up 5.1% from the prior quarter. For the full fiscal 2025 it was $3.57M, up 32.9% from fiscal 2024. It rose in 2 of the last 3 fiscal years.

NRXS net incomeQ3 2026-$6.55M

NRXS net income was -$6.55M in fiscal Q3 2026 (ended Sep 30, 2026), compared with -$2.12M a year earlier. For the full fiscal 2025 it was -$7.80M, compared with -$8.24M in fiscal 2024.

NRXS EPSQ3 2026-$0.52

NRXS diluted EPS was -$0.52 in fiscal Q3 2026 (ended Sep 30, 2026), compared with -$0.24 a year earlier. For the full fiscal 2025 it was -$0.95, compared with -$1.22 in fiscal 2024.

NRXS free cash flowQ3 2026-$2.27M

NRXS free cash flow was -$2.27M in fiscal Q3 2026 (ended Sep 30, 2026), compared with -$1.43M a year earlier. For the full fiscal 2025 it was -$6.46M, compared with -$6.13M in fiscal 2024.

Export CSV

Income statement

Income statement
Line item
Dec 31, 2025
Dec 31, 2024
Dec 31, 2023
Dec 31, 2022
Revenue$3.57M$2.69M$2.46M$2.68M
Cost of revenue$562.9K$362.0K$303.3K$297.1K
Gross profit$3.01M$2.32M$2.16M$2.39M
Research and development$493.6K$433.6K$169.3K$225.6K
Selling, general and admin$8.06M$7.58M$8.33M$5.12M
Operating income-$7.83M-$7.16M-$6.66M-$3.37M
Interest expense$74.0K$174.3K$476.4K$318.7K
Net income-$7.80M-$8.24M-$14.63M-$4.78M
EPS, basic-$0.95-$1.22-$4.50-$2.77
EPS, diluted-$0.95-$1.22-$4.50-$2.77
Diluted shares9.1M6.9M3.3M2.0M

Balance sheet

Balance sheet
Line item
Dec 31, 2025
Dec 31, 2024
Dec 31, 2023
Dec 31, 2022
Cash and equivalents$4.97M$3.70M$78.6K$253.7K
Receivables$195.7K$244.6K$73.2K$174.4K
Inventory$257.1K$44.3K$21.2K$48.1K
Current assets$5.73M$4.27M$242.6K$477.0K
Total assets$6.40M$4.76M$509.5K$1.48M
Current liabilities$2.79M$2.43M$1.89M$6.98M
Short-term debt$148.3K$154.2K$148.1K-
Total debt---$228.3K
Total liabilities$3.00M$2.69M$1.91M$7.05M
Shareholders' equity$3.40M$2.07M-$1.40M-$5.57M

Cash flow

Cash flow
Line item
Dec 31, 2025
Dec 31, 2024
Dec 31, 2023
Dec 31, 2022
Operating cash flow-$6.43M-$6.10M-$6.69M-$2.30M
Capital expenditures$31.1K$27.8K$30.8K$1.4K
Free cash flow-$6.46M-$6.13M-$6.72M-$2.30M
Investing cash flow-$131.2K-$27.8K-$71.8K-$61.2K
Financing cash flow$7.83M$9.74M$6.59M$2.29M
Stock-based compensation$596.9K$227.0K$0$27.3K
Depreciation and amortization$59.5K$37.8K$40.7K$37.1K

Key ratios

Key ratios
Line item
Dec 31, 2025
Dec 31, 2024
Dec 31, 2023
Dec 31, 2022
Revenue growth, YoY32.9%9.2%-8.4%-
Gross margin84.2%86.5%87.7%88.9%
Operating margin-219.4%-266.5%-270.9%-125.6%
Net margin-218.5%-306.8%-594.6%-178.0%
Free cash flow margin-181.1%-228.1%-273.4%-85.6%
Return on equity-229.5%-398.6%--
Return on assets-121.8%-173.2%-2870.8%-322.8%
Current ratio2.051.750.130.07

Source: XBRL data Neuraxis Inc. files with the SEC, latest filing dated Nov 9, 2026 (see filings on SEC EDGAR). Provided for information only, not investment advice. Check the filing before relying on a number.

* Worked out from the filings rather than stated in them: Q4 is the full year less the first nine months.

Per-share figures are as filed. The filings show no stock split in these periods.

EPS growth is left out where the share count moved enough to suggest a split the filings do not show. Growth rates need a positive starting figure. CAGR is compound annual growth between fiscal years. The CSV holds every period on file, in full figures, from the same SEC filings.

NRXS peers

CompanyRevenueGrowthNet incomeNet marginMarket cap
NRXS$6.53M+94.3%-$12.10M-185.2%$76.9M
MDT$37.54B+9.8%$5.24B14.0%$131.57B
LIVN$1.51B+11.7%$196.06M13.0%$5.03B
ITGR$1.83B-0.3%$103.70M5.7%$4.31B
AXGN$266.93M+24.3%-$31.92M-12.0%$3.34B
TMDX$727.65M+28.5%$144.45M19.9%$3.17B
CNMD$1.37B+1.6%$73.43M5.4%$1.51B
CBLL$108.72M+31.3%-$73.88M-68.0%$1.02B
INMD$370.50M-6.2%$93.83M25.3%$762.8M

NRXS FAQ

7 questions
  • What is NRXS revenue?
    Neuraxis Inc. (NRXS) reported $6.53M of revenue for the twelve months ended Sep 30, 2026. That is up 94.3% from the year before. Revenue for fiscal 2025 was $3.57M.
  • Is NRXS profitable?
    No. Neuraxis Inc. reported a net loss of $12.10M for the twelve months ended Sep 30, 2026.
  • How much cash and debt does NRXS have?
    Neuraxis Inc. reported $4.48M in cash and cash equivalents on its most recent balance sheet in SEC filings.
  • How fast is NRXS revenue growing?
    Neuraxis Inc.'s revenue changed +32.9% in fiscal 2025, to $3.57M.
  • What is NRXS gross margin?
    Neuraxis Inc.'s gross profit was $5.63M on $6.53M of revenue for the twelve months ended Sep 30, 2026, a gross margin of 86.2%.
  • When did NRXS last report financial results?
    The latest statements here come from Neuraxis Inc.'s 10-Q filed on Nov 9, 2026, covering the period ended Sep 30, 2026.
  • Where does this NRXS financial data come from?
    Quantisnow builds these statements from the structured XBRL data Neuraxis Inc. files with the SEC. It is provided for information only and is not investment advice.